Emyria (ASX:EMD) Share Price and News

Market Cap (16-May) $17,684,784 (923rd)	Close (30-Jun) $0.125 0 (0%)	Volume (30-Jun) 0	Shortsold (17-Apr) 8,415 (0.00%) (600th)
52w High $0.064	52w Low $0.021	P/E -	EPS 0

	Subject
	EMD EMD Ann: Trading Halt
	1 (current) 2 3
	EMD EMD Ann: Emyria Receives Ethics Approval for MDMA-assisted Therapy
	EMD EMD Ann: Section 708A(5)(e) Notice
	EMD EMD Ann: Application for quotation of securities - EMD
	EMD EMD Ann: Notification regarding unquoted securities - EMD
	EMD EMD Ann: Proposed issue of securities - EMD
	EMD EMD Ann: Emyria Completes $2.5m Placement
	EMD EMD Ann: March 2023 Quarterly Activities Report and Appendix 4C
	EMD EMD Ann: Trading Halt
	EMD EMD Ann: Emyria Unveils Highest Potency CBD Capsule for FDA Pathway
	EMD EMD Ann: Emyria to Develop Psilocybin Therapy Care Model
	EMD EMD Ann: Emyria, Aspen Sign Binding Commercial Term Sheet for EMD-RX5
	EMD EMD Ann: Strong Recruitment for EMD-RX5 Phase 3 Trial
	EMD EMD Ann: Emyria Grows MDMA Asset for Neuro & Mental Health Therapy
	EMD EMD Ann: Broker Briefing Presentation
	EMD EMD Ann: Broker Briefing Biotech & Nutrition Investor Webinar
	EMD EMD Ann: Emyria partners with PAX Centre for MDMA-assisted therapy
	EMD EMD Ann: Company Secretary Change
	EMD EMD Ann: Notice under section 708A(5)(e) of the Corporations Act
	EMD EMD Ann: Half Yearly Report and Accounts
	EMD EMD Ann: Investor Presentation
	EMD EMD Ann: Change of Director's Interest Notice x 5
	EMD EMD Ann: Notification regarding unquoted securities - EMD
	EMD EMD Ann: Application for quotation of securities - EMD
	EMD EMD Ann: Emyria secures clinical-grade MDMA supply for Aust patients
	EMD EMD Ann: Emyria expands MDMA programs following landmark TGA decision
	EMD EMD Ann: Appendix 4C - Quarterly
	EMD EMD Ann: Change in substantial holding SW
	EMD EMD Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial
	EMD EMD Ann: Results of Meeting
	EMD EMD Ann: Emyria receives $2.1M R&D tax incentive refund
	EMD EMD Ann: Biotech Showcase San Francisco Presentation
	EMD EMD Ann: Notification of cessation of securities - EMD
	EMD EMD Ann: Letter to Shareholders/Notice of General Meeting/Proxy Form
	EMD EMD Ann: Notice under section 708A(5)(e) of the Corporations Act
	EMD EMD Ann: Application for quotation of securities - EMD
	EMD EMD Ann: Upcoming Emyria CEO Webinars
	EMD EMD Ann: Emyria accepted into National Institutes of Health Program
	EMD EMD Ann: Change of Director's Interest Notice
	EMD EMD Ann: Notification regarding unquoted securities - EMD
	EMD EMD Ann: Notification regarding unquoted securities - EMD
	EMD EMD Ann: Placement completion and secondary trading notice
	EMD EMD Ann: Investor Presentation
	EMD EMD Ann: Notification regarding unquoted securities - EMD
	EMD EMD Ann: Application for quotation of securities - EMD
	EMD EMD Ann: Notification of cessation of securities - EMD
	EMD EMD Ann: Amended Constitution
	EMD EMD Ann: Appendix 4C - Quarterly
	EMD EMD Ann: Proposed issue of securities - EMD
	EMD EMD Ann: Proposed issue of securities - EMD

Similar Companies

Estia Health

EHE

Japara Healthcare

JHC

Monash IVF Group

MVF

1300SMILES

ONT

Pacific Smiles Group

PSQ

Regis Healthcare

REG

Ramsay Health Care

RHC

Virtus Health

VRT

End of Day Prices

Date	Close	Volume	Change
15-May	$0.04	160,095	0.00 (0.00%)
14-May	$0.04	62,313	+0.00 (2.86%)
12-May	$0.04	885,236	0.00 (7.89%)
08-May	$0.04	1,834,385	+0.00 (8.57%)
07-May	$0.04	1,461,824	+0.01 (16.67%)
05-May	$0.03	400,687	0.00 (0.00%)
02-May	$0.03	27,920	0.00 (0.00%)
01-May	$0.03	185,146	+0.00 (7.14%)
30-Apr	$0.03	76,177	+0.00 (3.70%)
28-Apr	$0.03	53,119	+0.00 (3.85%)
24-Apr	$0.03	28,966	0.00 (13.33%)
17-Apr	$0.03	62,216	0.00 (3.23%)
16-Apr	$0.03	43,066	0.00 (0.00%)
14-Apr	$0.03	173,609	+0.00 (6.90%)
11-Apr	$0.03	105,580	+0.00 (16.00%)
8 up, 3 down, and 4 flat days

High -	Low -	Trades -	Turnover $0	Volume 0
16 May 2025 at 11:14am

High -	Low -	Trades -	Turnover $0	Volume 0
16 May 2025 at 11:14am

Emyria Health Care

$0.125 (0%)

$0.125 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices